Bladder Cancer Trial, Recruiting (NCT07424560)

Bladder Cancer Trial, Recruiting NCT07424560 Sponsor: Zhilong Dong Condition: Bladder Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07424560 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Bladder Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with bladder cancer (confirmed by a lab test looking at tissue under a microscope), at any stage.
There is enough tumor tissue from your biopsy or surgery that has been stored frozen, so it can be used for genetic testing.
You are 18 years old or older at the time of your diagnosis.

Who may not be able to join:

You have had another type of cancer in the past 5 years, unless it was a common, easily treated skin cancer or a very early-stage cervical condition that was fully treated.
The tumor tissue sample collected from you does not contain enough good-quality DNA to run the genetic tests needed for the study.
You are currently pregnant or breastfeeding.
You have a serious ongoing health condition that is not well controlled and could make it difficult to participate, such as an active infection, heart failure, unstable chest pain, an irregular heartbeat, or a mental health or personal situation that would make it hard to follow the study's requirements (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 9 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Zhilong Dong, Doctor of Medicine, Lanzhou University Second Hospital

Phone: +86 18221095087

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07424560

Sponsor: Zhilong Dong

Phase: Not Applicable

Status: Recruiting

Condition: Bladder Cancer

Trial contact: +86 18221095087

More information: https://clinicaltrials.gov/study/NCT07424560

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with bladder cancer (confirmed by a lab test looking at tissue under a microscope), at any stage.
There is enough tumor tissue from your biopsy or surgery that has been stored frozen, so it can be used for genetic testing.
You are 18 years old or older at the time of your diagnosis.

Who may not be able to join:

You have had another type of cancer in the past 5 years, unless it was a common, easily treated skin cancer or a very early-stage cervical condition that was fully treated.
The tumor tissue sample collected from you does not contain enough good-quality DNA to run the genetic tests needed for the study.
You are currently pregnant or breastfeeding.
You have a serious ongoing health condition that is not well controlled and could make it difficult to participate, such as an active infection, heart failure, unstable chest pain, an irregular heartbeat, or a mental health or personal situation that would make it hard to follow the study's requirements (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 9 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Zhilong Dong

Registry

ClinicalTrials.gov

Start date

25 February 2026

Est. completion

1 July 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Survival Differences Between Mutated and Non-mutated Groups in Bladder Cancer Patients

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov